Skip to main content

Nanogen, HandyLab Expand Probe Licensing Deal

NEW YORK (GenomeWeb News) – Nanogen today said that it has expanded a licensing agreement with HandyLab for the firm's probe technology and synthetic nucleic acid chemistries.

San Diego-based Nanogen said that HandyLab has received non-exclusive rights to market, sell, and distribute PCR kits that utilize its Minor Groove Binder Probe technology and related chemistries, dyes, and quenchers for in vitro diagnostic testing. HandyLab will use the technology in its Jaguar System.

HandyLab will pay Nanogen an upfront license fee. Other financial terms of the alliance were not disclosed.

The agreement expands an existing partnership between the firms that began last year when the US Centers for Disease Control and Prevention awarded a $10.4 million contract to Nanogen to develop a multi-analyte molecular diagnostic assay for influenza. That test is being developed for use with a HandyLab microfluidic, real-time PCR Raider instrument.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.